Enveric Biosciences (STU:SLZ0) OCF Margin %: 0.00% (As of Mar. 2026)


STU:SLZ0 Enveric Biosciences Inc STU:SLZ0
26 GF Score
Price €55.89
! 1 Warning Sign
View Full Analysis

What is Enveric Biosciences OCF Margin %?

Enveric Biosciences STU:SLZ0 26 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:SLZ0 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review. Among 958 Biotechnology companies, Enveric Biosciences ranks worse than 104384.03% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Enveric Biosciences's Cash Flow from Operations for the three months ended in Mar. 2026 was €-1.95 Mil. Enveric Biosciences's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Enveric Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Enveric Biosciences's current OCF Yield % is -139.98%.

The historical rank and industry rank for Enveric Biosciences's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Enveric Biosciences was -5.64%. The lowest was -7.48%. And the median was -6.06%.

STU:SLZ0's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Enveric Biosciences OCF Margin % Related Terms

Enveric Biosciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Enveric Biosciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enveric Biosciences OCF Margin % Chart

Enveric Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enveric Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:SLZ0
26GF Score
Enveric Biosciences Inc STU:SLZ0
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enveric Biosciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Enveric Biosciences's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-6.953/0
= %

Enveric Biosciences's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.952/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Enveric Biosciences (STU:SLZ0) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enveric Biosciences and its competitors. According to the industry distribution chart, Enveric Biosciences ranks #999999 out of 958 companies in the Biotechnology industry.
Is Enveric Biosciences' OCF Margin % too high?
Enveric Biosciences' current OCF Margin % is 0.00%. Based on the distribution chart, Enveric Biosciences ranks #999999 out of 958 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Enveric Biosciences has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Enveric Biosciences' OCF Margin % compare to ACXP and CELZ?
According to the Biotechnology industry distribution chart, Enveric Biosciences ranks #999999 out of 958 companies for OCF Margin %. This places Enveric Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Enveric Biosciences and its competitors. Enveric Biosciences's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enveric Biosciences stock overvalued right now?
Enveric Biosciences (STU:SLZ0) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Enveric Biosciences' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Enveric Biosciences (STU:SLZ0), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enveric Biosciences Business Description

Other Exchanges ENVB:USA
Address 245 First Street, 18th Floor, Riverview II, Cambridge, MA, USA, 02142
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
26GF Score

Get the complete analysis for STU:SLZ0

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.89
Price